Share This Article:

Fitting evolutionary process of matrix protein 2 family from influenza A virus using analytical solution of differential equation

Abstract Full-Text HTML Download Download as PDF (Size:307KB) PP. 587-593
DOI: 10.4236/jbise.2009.28085    3,883 Downloads   6,993 Views  

ABSTRACT

The evolution of protein family is a process along the time course, thus any mathematical methods that can describe a process over time could be possible to describe an evolutionary process. In our previously concept-initiated study, we attempted to use the differential equation to describe the evolution of hemagglutinins from influenza A viruses, and to discuss various issues related to the building of differential equation. In this study, we attempted not only to use the differential equation to describe the evolution of matrix protein 2 family from influenza A virus, but also to use the analytical solution to fit its evolutionary process. The results showed that the fitting was possible and workable. The fitted model parameters provided a way to further determine the evolutionary dynamics and kinetics, a way to more precisely predict the time of occurrence of mutation, and a way to figure out the interaction between protein family and its environment.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Yan, S. , Li, Z. and Wu, G. (2009) Fitting evolutionary process of matrix protein 2 family from influenza A virus using analytical solution of differential equation. Journal of Biomedical Science and Engineering, 2, 587-593. doi: 10.4236/jbise.2009.28085.

References

[1] S. Yan and G. Wu. (2009) Describing evolution of hemagglutinins from influenza A viruses using a differential equation, Protein Pept. Lett., 16, 794–804.
[2] G. Wu and S. Yan. (2002) Randomness in the primary structure of protein: Methods and implications, Mol. Biol. Today, 3, 55–69.
[3] G. Wu and S. Yan. (2006) Mutation trend of hemagglutinin of influenza A virus: A review from computational mutation viewpoint, Acta Pharmacol. Sin., 27, 513–526.
[4] G. Wu and S. Yan. (2006) Fate of influenza A virus proteins, Protein Pept. Lett., 13, 377–384.
[5] G. Wu and S. Yan. (2008) Lecture notes on computational mutation, Nova Science Publishers, New York.
[6] T. Betakova. (2007) M2 protein-a proton channel of influenza A virus, Curr. Pharm. Des., 13, 3231–3235.
[7] L. H. Pinto and R. A. Lamb. (2007) Controlling influenza virus replication by inhibiting its proton channel, Mol. Biosyst., 3, 18–23
[8] J. Beigel and M. Bray. (2008) Current and future antiviral therapy of severe seasonal and avian influenza, Antiviral Res., 78, 91–102.
[9] E. De Clercq and J. Neyts. (2007) Avian influenza A (H5N1) infection: Targets and strategies for chemotherapeutic intervention, Trends Pharmacol. Sci., 28, 280–285.
[10] F. Hayden. (2009) Developing new antiviral agents for influenza treatment: What does the future hold? Clin. Infect. Dis., 48, S3–S13.
[11] M. Schotsaert, M. De Filette, W. Fiers and X. Saelens. (2009) Universal M2 ectodomain-based influenza A vaccines: Preclinical and clinical developments, Expert Rev. Vaccines, 8, 499–508.
[12] Influenza virus resources, (2009) http://www.ncbi.nlm.nih.gov/genomes/FLU/Database/multiple.cgi.
[13] SPSS Inc., (2002) SigmaPlot for Windows, Version 8.02.
[14] G. Wu. (1996) Fit fluctuating blood drug concentration: A beginner’s first note, Pharmacol. Res., 33, 379–383.
[15] K. Yamaoka, T. Nakagawa and T. Uno. (1978) Application of Akaike’s information criterion (AIC) in the eva- luation of linear pharmacoketic equations, J. Pharmacokinet. Biopharm., 6, 165–175.
[16] G. Wu, P. Cossettini and M. Furlanut. (1996) Prediction of blood cyclosporine concentrations in haematological patients with multidrug resistance by one-, two- and three-compartment models using Bayesian and nonlinear least squares methods, Pharmacol. Res., 34, 47–57.
[17] G. Wu and S. Yan. (2006) Timing of mutation in hemagglutinins from influenza A virus by means of amino-acid distribution rank and fast Fourier transform, Protein Pept. Lett., 13, 143–148.
[18] G. Wu and S. Yan. (2005) Timing of mutation in hemagglutinins from influenza A virus by means of unpredictable portion of amino-acid pair and fast Fourier transform, Biochem. Biophys. Res. Commun., 333, 70–78.
[19] G. Wu and S. Yan. (2005) Searching of main cause leading to severe influenza A virus mutations and consequently to influenza pandemics/epidemics, Am. J. Infect. Dis., 1, 116–123.
[20] S. Yan and G. Wu. (2009) Prediction of mutation position, mutated amino acid and timing in hemagglutinins from North America H1 influenza A virus, J. Biomed. Sci. Eng, 2, 190–199.

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.